- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04904666
Safety and Efficacy of Bleach Baths in Non Critical Hospitalized Patients
Non critical hospitalized patients were bathed daily with 4 substances: bleach at .005%, bleach at .0125%, clorhexidine 2% and soap and water.
76 patients were enrolled and divided 19 subjects per group. Each patient was cultured with swab technique in palm, antecubital fold and armpit at day 0, day 3 and day 7 of enrollment.
Bacterial cultures were incubated and compared if decolonization occurred. Adverse events were evaluated in all patients.
Only 1 patient had and adverse event and was dry skin. Before patient was enrolled, he had dry skin because of his baseline disease. Moisturizing lotion was applied and patient continue in the study.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Nuevo Leon
-
Monterrey, Nuevo Leon, Mexico, 64460
- Hospital Universitario José E. Gonzalez
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Non critical hospitalized patients in internal medicine
- 18 years old and older
Exclusion Criteria:
- Burn patients
- Pregnant women
- Chloride hypersensitivity
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Bleach baths with .0125%
|
|
Clorhexidine 2%
|
|
Soap and water
|
|
Bleach baths with .005%
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Safety of Bleach baths as determined by the incidence of adverse or serious adverse events
Time Frame: November 26, 2019 - October 25, 2020
|
November 26, 2019 - October 25, 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of bacterial colonization from pathogens belonging to the ESKAPE group
Time Frame: November 26, 2019 - October 25, 2020
|
Identification of colonization by Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species
|
November 26, 2019 - October 25, 2020
|
|
Percentage of patients remaining colonized 3, 5 and 7 days after daily baths
Time Frame: November 26, 2019 - October 25, 2020
|
November 26, 2019 - October 25, 2020
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IF19-00010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Safety Issues
-
Shenyang Sunshine Pharmaceutical Co., LTD.Recruiting
-
Chulalongkorn UniversityNot yet recruiting
-
IC-MedTech CorporationCompleted
-
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics...Active, not recruiting
-
Mansoura UniversityCompleted
-
Showa Inan General HospitalCompleted
-
Asmaa Elwan Mohammed HassanCompleted
-
Hadassah Medical OrganizationGals Bio Ltd.Withdrawn
-
Federico II UniversityCompleted
-
Institute of Nuclear Energy Research, TaiwanCompleted